---
title: Divi's Laboratories vs DSK InnoSciences Ltd
slug_a: divislabs
slug_b: dskinnosciences
site: cdmo
review_signal_gate: closed
canonical_path: /compare/divislabs/dskinnosciences
---

# Divi's Laboratories vs DSK InnoSciences Ltd

Side-by-side profile data from each company listing on this directory.

## Divi's Laboratories

- Profile: [/companies/divislabs](/companies/divislabs)

Divi's Laboratories — World's largest API manufacturer and trusted CDMO partner for 25+ years, offering generic APIs, custom synthesis, peptides, and nutraceutical ingredients to 100+ countries with complete backward integration and green chemistry principles.

Services: 9. Modalities: 2. Indications: 0. Locations: 7. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Peptide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Peptide

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- Flow Chemistry

## DSK InnoSciences Ltd

- Profile: [/companies/dskinnosciences](/companies/dskinnosciences)

DSK InnoSciences Ltd — DSK InnoSciences is an established contract chemistry services company in Bangalore, India, offering synthesis, process development, and manufacturing of pharmaceuticals, specialty chemicals, and peptides from milligram to kilogram scale.

Services: 6. Modalities: 2. Indications: 0. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (6).

### Services

- Analytical Method Development & Validation
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Peptide Manufacturing
- Process Development
- CMC Analytical Development

### Modalities

- Small Molecule
- Peptide

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)
- Cryogenic (−80 °C)